— Know what they know.
Not Investment Advice
Also trades as: 0R2H.L (LSE) · $vol 34M · TII.DE (XETRA) · $vol 0M · TXN.BA (BUE) · $vol 0M

TXN NASDAQ

Texas Instruments Incorporated
1W: -3.2% 1M: +26.9% 3M: +35.8% YTD: +69.2% 1Y: +60.7% 3Y: +97.1% 5Y: +85.5%
$309.21
+10.82 (+3.63%)
 
Weekly Expected Move ±10.5%
$239 $271 $303 $334 $366
NASDAQ · Technology · Semiconductors · Alpha Radar Buy · Power 71 · $281.4B mcap · 908M float · 0.796% daily turnover · Short 48% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.9 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 21.2%  ·  5Y Avg: 34.6%
Cost Advantage
78
Intangibles
47
Switching Cost
26
Network Effect
45
Scale ★
95
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TXN shows a Weak competitive edge (54.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 21.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$250
Low
$303
Avg Target
$400
High
Based on 13 analysts since Apr 22, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 30Hold: 28Sell: 7Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$288.12
Analysts17
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 Seaport Global Jay Goldberg Initiated $400 +34.1% $298.39
2026-05-19 Mizuho Securities $215 $300 +85 -0.2% $300.60
2026-05-15 Stifel Nicolaus $290 $340 +50 +12.5% $302.10
2026-04-23 Wolfe Research $230 $315 +85 +12.6% $279.72
2026-04-23 Truist Financial $250 $278 +28 +0.7% $276.18
2026-04-23 UBS $260 $295 +35 +7.9% $273.49
2026-04-23 Stifel Nicolaus Tore Svanberg $250 $290 +40 +5.6% $274.50
2026-04-23 Cantor Fitzgerald $250 $280 +30 +2.3% $273.61
2026-04-23 Susquehanna $225 $300 +75 +27.0% $236.31
2026-04-23 Robert W. Baird Tristan Gerra $225 $300 +75 +27.0% $236.31
2026-04-23 KeyBanc $250 $325 +75 +37.5% $236.31
2026-04-23 Jefferies $185 $260 +75 +10.0% $236.31
2026-04-23 Barclays Tom O&#039;Malley $175 $250 +75 +5.8% $236.31
2026-04-16 Mizuho Securities Vijay Rakesh $160 $215 +55 -3.6% $223.10
2026-04-09 Stifel Nicolaus $215 $250 +35 +16.3% $214.98
2026-02-23 Truist Financial $175 $250 +75 +12.7% $221.78
2026-02-23 Cantor Fitzgerald Matthew Prisco $225 $250 +25 +13.1% $221.05
2026-01-28 Raymond James Initiated $240 +11.7% $214.89
2026-01-28 UBS Timothy Arcuri $245 $260 +15 +23.0% $211.31
2026-01-28 Mizuho Securities $145 $160 +15 -24.2% $211.06
2026-01-28 Goldman Sachs $156 $175 +19 -17.1% $211.16
2026-01-28 Morgan Stanley $175 $180 +5 -8.5% $196.63
2026-01-28 Robert W. Baird Tristan Gerra $195 $225 +30 +14.4% $196.63
2026-01-28 Stifel Nicolaus Tore Svanberg $170 $215 +45 +9.3% $196.63
2026-01-28 Cantor Fitzgerald Matthew Prisco $190 $225 +35 +14.4% $196.63
2026-01-28 Bernstein $140 $205 +65 +4.3% $196.63
2026-01-28 Wells Fargo $185 $215 +30 +9.3% $196.63
2026-01-28 Barclays Tom O'Malley $140 $175 +35 -11.0% $196.63
2026-01-22 Susquehanna Christopher Rolland $200 $225 +25 +15.7% $194.41
2026-01-22 BNP Paribas David O'Connor Initiated $190 -2.3% $194.41
2026-01-15 Barclays Tom O'Malley $125 $140 +15 -27.6% $193.45
2026-01-15 Wells Fargo Joe Quatrochi $190 $185 -5 -4.4% $193.45
2025-12-16 Cantor Fitzgerald $170 $190 +20 +6.9% $177.77
2025-12-15 Goldman Sachs $200 $156 -44 -13.1% $179.45
2025-10-22 Mizuho Securities $170 $145 -25 -19.8% $180.84
2025-10-22 Truist Financial William Stein $198 $175 -23 -3.2% $180.84
2025-10-22 UBS Timothy Arcuri $255 $245 -10 +35.5% $180.84
2025-10-22 Morgan Stanley $167 $175 +8 -3.2% $180.84
2025-10-22 Cantor Fitzgerald Initiated $170 -6.0% $180.84
2025-10-22 Stifel Nicolaus $160 $170 +10 -6.0% $180.84
2025-10-22 Robert W. Baird Tristan Gerra $175 $195 +20 +7.8% $180.84
2025-10-22 Susquehanna Christopher Rolland $215 $200 -15 +10.6% $180.84
2025-10-22 Goldman Sachs James Schneider $190 $200 +10 +10.6% $180.84
2025-07-28 Wolfe Research Chris Caso Initiated $230 +24.3% $184.99
2025-07-22 UBS Timothy Arcuri $215 $255 +40 +18.8% $214.57
2025-06-16 Wells Fargo Joe Quatrochi $150 $190 +40 -4.6% $199.22
2025-04-24 Mizuho Securities Vijay Rakesh $200 $170 -30 +4.9% $162.13
2025-04-24 UBS Timothy Arcuri $225 $215 -10 +32.6% $162.13
2025-04-22 Barclays Tom O'Malley $200 $125 -75 -14.8% $146.76
2025-04-14 UBS Timothy Arcuri $250 $225 -25 +49.0% $150.98

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
3
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TXN receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

74 Grade A+
Profitability
93
Balance Sheet
77
Earnings Quality
75
Growth
61
Value
45
Momentum
85
Safety
100
Cash Flow
70
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TXN scores highest in Safety (100/100) and lowest in Value (45/100). An overall grade of A+ places TXN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
9.47
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.69
Unlikely Manipulator
Ohlson O-Score
-9.60
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 83.8/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.46x
Accruals: -7.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TXN scores 9.47, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TXN scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TXN's score of -2.69 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TXN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TXN receives an estimated rating of AA- (score: 83.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TXN's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
52.37x
PEG
4.98x
P/S
15.26x
P/B
16.75x
P/FCF
47.69x
P/OCF
22.68x
EV/EBITDA
22.76x
EV/Revenue
10.19x
EV/EBIT
28.04x
EV/FCF
50.51x
Earnings Yield
3.02%
FCF Yield
2.10%
Shareholder Yield
3.40%
Graham Number
$48.50
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 52.4x earnings, TXN is priced for high growth expectations. Graham's intrinsic value formula yields $48.50 per share, 538% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.873
NI / EBT
×
Interest Burden
0.917
EBT / EBIT
×
EBIT Margin
0.364
EBIT / Rev
×
Asset Turnover
0.526
Rev / Assets
×
Equity Multiplier
2.113
Assets / Equity
=
ROE
32.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TXN's ROE of 32.4% is driven by Asset Turnover (0.526), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
10.38%
Fair P/E
29.26x
Intrinsic Value
$171.80
Price/Value
1.13x
Margin of Safety
-13.01%
Premium
13.01%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TXN's realized 10.4% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. TXN trades at a 13% premium to its adjusted intrinsic value of $171.80, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 29.3x compares to the current market P/E of 52.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$309.21
Median 1Y
$349.73
5th Pctile
$206.68
95th Pctile
$592.72
Ann. Volatility
33.0%
Analyst Target
$288.12
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Haviv Ilan Director,
President & Chief Executive Officer
$1,295,833 $9,000,071 $22,669,509
Richard Templeton
Chairman of the board
$600,000 $3,750,139 $8,288,371
Hagop Kozanian
Senior Vice President
$827,500 $2,550,154 $7,498,129
Amichai Ron
Senior Vice President
$807,500 $2,550,154 $7,428,828
Rafael Lizardi &
enior Vice President & Chief Financial Officer
$872,500 $2,400,156 $7,113,119

CEO Pay Ratio

402:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,669,509
Avg Employee Cost (SGA/emp): $56,364
Employees: 33,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
33,000
-2.9% YoY
Revenue / Employee
$535,818
Rev: $17,682,000,000
Profit / Employee
$151,545
NI: $5,001,000,000
SGA / Employee
$56,364
Avg labor cost proxy
R&D / Employee
$63,121
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 74.3% 80.9% 69.0% 73.0% 76.2% 79.3% 62.7% 59.2% 55.1% 50.9% 41.4% 37.5% 33.8% 31.5% 28.4% 28.8% 29.8% 29.8% 30.1% 32.4% 32.35%
ROA 36.0% 39.2% 35.3% 37.3% 39.0% 40.5% 33.7% 31.8% 29.6% 27.4% 21.9% 19.8% 17.8% 16.7% 14.1% 14.4% 14.9% 14.9% 14.3% 15.3% 15.31%
ROIC 68.0% 74.1% 66.1% 70.2% 73.8% 76.7% 60.6% 56.9% 52.6% 48.3% 32.9% 29.9% 26.9% 25.3% 21.0% 21.5% 22.6% 22.9% 19.7% 21.2% 21.21%
ROCE 46.5% 50.5% 41.2% 43.9% 45.9% 47.6% 42.3% 40.0% 37.3% 34.5% 26.8% 24.7% 22.2% 21.1% 18.7% 18.7% 19.4% 19.5% 19.9% 21.3% 21.33%
Gross Margin 67.2% 67.9% 69.3% 70.2% 69.6% 69.0% 66.1% 65.4% 64.2% 62.1% 59.6% 57.2% 57.8% 59.6% 57.7% 56.8% 57.9% 57.4% 55.9% 58.0% 58.01%
Operating Margin 48.3% 49.6% 51.8% 52.3% 52.2% 51.1% 46.6% 44.2% 43.5% 41.7% 37.6% 35.1% 32.7% 37.4% 34.4% 32.5% 35.1% 35.1% 33.3% 37.5% 37.47%
Net Margin 42.2% 41.9% 44.2% 44.9% 44.0% 43.8% 42.0% 39.0% 38.0% 37.7% 33.6% 30.2% 29.5% 32.8% 30.1% 29.0% 29.1% 28.8% 26.3% 32.0% 32.02%
EBITDA Margin 55.3% 55.4% 56.4% 56.9% 57.0% 56.7% 53.3% 52.4% 52.8% 51.6% 48.6% 48.4% 46.0% 50.3% 48.0% 45.4% 47.0% 47.3% 46.8% 38.4% 38.45%
FCF Margin 38.7% 40.6% 34.3% 34.0% 30.1% 29.3% 29.6% 22.6% 16.9% 9.1% 7.7% 5.6% 9.3% 9.3% 9.6% 9.1% 9.0% 12.0% 14.7% 20.2% 20.18%
OCF Margin 45.0% 48.5% 47.7% 47.7% 44.4% 44.7% 43.5% 39.7% 39.1% 36.1% 36.6% 37.4% 40.1% 39.7% 40.4% 38.3% 38.6% 39.9% 40.5% 42.4% 42.43%
ROE 3Y Avg snapshot only 32.26%
ROE 5Y Avg snapshot only 43.01%
ROA 3Y Avg snapshot only 15.83%
ROIC 3Y Avg snapshot only 21.59%
ROIC Economic snapshot only 18.15%
Cash ROA snapshot only 22.62%
Cash ROIC snapshot only 29.21%
CROIC snapshot only 13.89%
NOPAT Margin snapshot only 30.81%
Pretax Margin snapshot only 33.34%
R&D / Revenue snapshot only 11.26%
SGA / Revenue snapshot only 10.04%
SBC / Revenue snapshot only 2.23%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 23.51 21.69 20.16 18.64 14.99 14.50 15.79 18.98 19.88 19.14 22.56 25.67 32.17 36.83 34.78 32.96 36.96 33.00 31.67 33.06 52.370
P/S Ratio 9.43 9.03 8.54 8.08 6.56 6.41 6.90 8.03 8.12 7.50 8.38 9.02 10.62 11.64 10.67 10.01 11.17 9.64 8.96 9.62 15.262
P/B Ratio 17.21 17.28 11.75 11.49 9.64 9.71 9.48 10.75 10.48 9.32 8.69 8.97 10.11 10.82 9.87 9.50 11.02 9.85 9.73 10.90 16.752
P/FCF 24.37 22.26 24.89 23.74 21.83 21.85 23.33 35.61 48.02 82.47 108.88 161.30 114.39 124.56 111.41 110.38 123.97 80.02 60.85 47.69 47.687
P/OCF 20.97 18.62 17.89 16.92 14.78 14.32 15.85 20.25 20.74 20.79 22.88 24.16 26.50 29.29 26.42 26.11 28.94 24.13 22.14 22.68 22.679
EV/EBITDA 17.90 16.68 15.42 14.27 11.49 11.16 12.31 14.61 15.06 14.28 16.60 18.18 22.10 24.41 22.93 21.87 24.19 21.28 20.47 22.76 22.757
EV/Revenue 9.47 9.06 8.45 8.00 6.48 6.33 6.90 8.03 8.12 7.50 8.53 9.18 10.78 11.81 11.06 10.38 11.53 9.99 9.55 10.19 10.194
EV/EBIT 20.13 18.60 17.04 15.64 12.53 12.14 13.49 16.18 16.90 16.27 19.24 21.53 26.89 30.32 29.01 27.97 31.08 27.69 27.01 28.04 28.036
EV/FCF 24.46 22.34 24.64 23.50 21.57 21.59 23.33 35.61 48.02 82.48 110.84 164.12 116.16 126.37 115.43 114.51 127.97 82.91 64.89 50.51 50.512
Earnings Yield 4.3% 4.6% 5.0% 5.4% 6.7% 6.9% 6.3% 5.3% 5.0% 5.2% 4.4% 3.9% 3.1% 2.7% 2.9% 3.0% 2.7% 3.0% 3.2% 3.0% 3.02%
FCF Yield 4.1% 4.5% 4.0% 4.2% 4.6% 4.6% 4.3% 2.8% 2.1% 1.2% 0.9% 0.6% 0.9% 0.8% 0.9% 0.9% 0.8% 1.2% 1.6% 2.1% 2.10%
PEG Ratio snapshot only 4.985
Price/Tangible Book snapshot only 15.160
EV/OCF snapshot only 24.023
EV/Gross Profit snapshot only 17.784
Acquirers Multiple snapshot only 28.885
Shareholder Yield snapshot only 3.40%
Graham Number snapshot only $48.50
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.28 4.28 5.33 5.33 5.33 5.33 4.70 4.70 4.70 4.70 4.55 4.55 4.55 4.55 4.12 4.12 4.12 4.12 4.35 4.35 4.353
Quick Ratio 3.47 3.47 4.58 4.58 4.58 4.58 3.77 3.77 3.77 3.77 3.35 3.35 3.35 3.35 2.88 2.88 2.88 2.88 2.83 2.83 2.832
Debt/Equity 0.77 0.77 0.62 0.62 0.62 0.62 0.62 0.62 0.62 0.62 0.66 0.66 0.66 0.66 0.80 0.80 0.80 0.80 0.95 0.95 0.946
Net Debt/Equity 0.06 0.06 -0.11 -0.11 -0.11 -0.11 0.00 0.00 0.00 0.00 0.16 0.16 0.16 0.16 0.36 0.36 0.36 0.36 0.65 0.65 0.646
Debt/Assets 0.37 0.37 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.35 0.35 0.35 0.35 0.38 0.38 0.38 0.38 0.45 0.45 0.445
Debt/EBITDA 0.80 0.75 0.82 0.77 0.74 0.72 0.81 0.85 0.89 0.95 1.25 1.32 1.43 1.48 1.80 1.78 1.71 1.68 1.87 1.86 1.864
Net Debt/EBITDA 0.06 0.06 -0.15 -0.14 -0.14 -0.13 0.00 0.00 0.00 0.00 0.29 0.31 0.34 0.35 0.80 0.79 0.76 0.74 1.27 1.27 1.273
Interest Coverage 42.15 46.81 49.47 51.03 52.00 51.88 47.88 42.10 33.49 26.51 22.01 17.87 14.57 12.85 11.73 11.45 11.86 11.71 11.52 12.06 12.058
Equity Multiplier 2.11 2.11 1.85 1.85 1.85 1.85 1.87 1.87 1.87 1.87 1.91 1.91 1.91 1.91 2.10 2.10 2.10 2.10 2.13 2.13 2.125
Cash Ratio snapshot only 1.545
Debt Service Coverage snapshot only 14.854
Cash to Debt snapshot only 0.317
FCF to Debt snapshot only 0.242
Defensive Interval snapshot only 615.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.90 0.94 0.83 0.86 0.89 0.92 0.77 0.75 0.73 0.70 0.59 0.56 0.54 0.53 0.46 0.47 0.49 0.51 0.50 0.53 0.526
Inventory Turnover 2.93 2.99 3.09 3.07 3.12 3.19 2.68 2.70 2.72 2.76 1.92 1.94 1.94 1.92 1.54 1.58 1.64 1.72 1.63 1.69 1.687
Receivables Turnover 13.47 14.14 11.78 12.17 12.58 12.96 11.14 10.85 10.47 10.07 9.52 9.13 8.74 8.53 8.92 9.16 9.51 9.85 9.60 10.02 10.015
Payables Turnover 14.42 14.73 12.11 12.05 12.22 12.49 8.80 8.87 8.92 9.05 7.86 7.92 7.91 7.86 8.07 8.31 8.63 9.05 9.64 9.99 9.986
DSO 27 26 31 30 29 28 33 34 35 36 38 40 42 43 41 40 38 37 38 36 36.4 days
DIO 125 122 118 119 117 115 136 135 134 132 190 188 189 190 238 231 222 212 224 216 216.4 days
DPO 25 25 30 30 30 29 41 41 41 40 46 46 46 46 45 44 42 40 38 37 36.6 days
Cash Conversion Cycle 126 123 119 118 116 114 127 128 128 128 182 182 184 186 233 227 218 209 224 216 216.3 days
Fixed Asset Turnover snapshot only 1.497
Operating Cycle snapshot only 252.9 days
Cash Velocity snapshot only 3.778
Capital Intensity snapshot only 1.876
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 22.4% 28.1% 26.9% 22.9% 16.9% 14.8% 9.2% 2.9% -3.9% -10.3% -12.5% -13.8% -14.5% -13.3% -10.7% -4.5% 3.6% 9.9% 13.0% 14.9% 14.89%
Net Income 33.2% 47.1% 38.9% 33.1% 27.5% 21.9% 12.6% 0.5% -10.4% -20.4% -25.6% -28.5% -30.9% -30.1% -26.3% -17.5% -5.1% 1.6% 4.2% 10.1% 10.14%
EPS 31.8% 46.0% 38.3% 33.2% 28.5% 23.7% 15.1% 2.4% -9.0% -19.8% -25.5% -28.5% -31.1% -30.4% -26.6% -17.4% -4.4% 2.2% 4.9% 10.4% 10.38%
FCF 13.5% 38.0% 14.6% 1.8% -9.2% -17.0% -5.9% -31.8% -46.0% -72.2% -77.2% -78.6% -53.0% -10.9% 11.0% 54.8% 0.6% 41.7% 73.8% 1.6% 1.56%
EBITDA 35.4% 46.2% 39.7% 34.4% 24.8% 20.0% 11.6% 1.0% -8.2% -17.0% -19.7% -20.9% -22.6% -20.1% -16.3% -10.2% 1.2% 6.7% 9.4% 8.4% 8.41%
Op. Income 42.6% 55.2% 52.0% 45.5% 33.3% 26.6% 13.2% -0.8% -13.2% -23.8% -27.7% -29.7% -32.0% -29.5% -25.5% -17.7% -2.4% 5.4% 10.2% 18.2% 18.24%
OCF Growth snapshot only 27.22%
Asset Growth snapshot only -2.60%
Equity Growth snapshot only -3.73%
Debt Growth snapshot only 13.20%
Shares Change snapshot only -0.22%
Dividend Growth snapshot only 4.16%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 2.3% 3.6% 5.1% 6.7% 8.7% 11.0% 11.7% 11.4% 11.2% 9.7% 6.6% 2.9% -1.4% -3.7% -5.2% -5.4% -5.2% -5.1% -4.1% -1.9% -1.85%
Revenue 5Y 5.4% 6.0% 6.5% 6.6% 6.7% 6.7% 6.0% 4.9% 3.7% 2.7% 2.1% 1.5% 1.1% 1.3% 1.7% 2.6% 4.0% 4.7% 4.1% 3.6% 3.64%
EPS 3Y 17.6% 18.2% 13.0% 15.7% 18.1% 21.0% 21.8% 19.6% 15.5% 13.1% 5.8% -0.8% -7.0% -11.6% -14.3% -15.4% -15.7% -17.1% -16.9% -13.3% -13.31%
EPS 5Y 18.2% 19.0% 19.0% 18.5% 18.1% 17.3% 21.2% 17.5% 13.7% 10.4% 4.3% 2.5% 0.7% -0.2% -0.3% 0.2% 0.3% 0.6% -1.8% -2.3% -2.32%
Net Income 3Y 15.2% 16.0% 11.7% 14.8% 17.2% 19.8% 20.4% 18.4% 15.0% 12.6% 5.2% -1.5% -7.6% -12.1% -14.8% -16.0% -16.2% -17.3% -17.0% -13.4% -13.37%
Net Income 5Y 16.3% 17.0% 17.0% 16.5% 16.1% 15.3% 18.9% 15.3% 11.8% 8.7% 3.1% 1.7% -0.1% -0.9% -0.9% -0.4% -0.0% 0.3% -2.2% -2.8% -2.76%
EBITDA 3Y 5.2% 7.1% 9.0% 11.6% 13.9% 16.8% 17.3% 16.4% 15.7% 13.4% 7.8% 2.4% -4.0% -7.3% -9.2% -10.5% -10.4% -10.9% -9.7% -8.3% -8.35%
EBITDA 5Y 10.2% 11.1% 11.0% 11.2% 10.8% 10.3% 9.7% 7.8% 5.9% 4.1% 3.0% 2.1% 1.0% 1.1% 1.7% 2.3% 4.0% 4.4% 2.8% 0.9% 0.88%
Gross Profit 3Y 2.6% 4.2% 6.4% 8.9% 11.3% 14.0% 14.5% 13.6% 12.7% 10.2% 5.9% 0.9% -4.5% -7.6% -9.8% -10.6% -10.7% -10.9% -9.9% -7.1% -7.12%
Gross Profit 5Y 7.4% 7.9% 8.5% 8.8% 8.7% 8.6% 7.5% 5.9% 4.2% 2.5% 1.4% 0.3% -0.6% -0.6% -0.2% 0.7% 2.1% 2.6% 1.7% 1.2% 1.16%
Op. Income 3Y 4.6% 7.0% 10.1% 13.6% 16.8% 20.4% 21.0% 19.4% 18.2% 14.4% 7.5% 0.5% -7.7% -12.1% -15.2% -16.9% -16.8% -17.3% -15.9% -11.9% -11.88%
Op. Income 5Y 11.5% 12.3% 13.3% 13.5% 13.1% 12.4% 10.8% 8.3% 5.8% 3.4% 1.8% 0.4% -1.2% -1.3% -0.9% -0.3% 1.8% 2.1% 0.4% -0.3% -0.25%
FCF 3Y 4.2% 6.3% 1.3% 2.5% -0.2% -0.6% 0.7% -7.9% -17.7% -31.7% -37.4% -47.1% -38.7% -41.0% -38.0% -39.1% -36.6% -29.4% -24.0% -5.4% -5.43%
FCF 5Y 10.9% 13.0% 10.1% 9.3% 8.1% 6.9% 4.9% -2.2% -11.1% -22.6% -25.9% -31.0% -24.1% -24.6% -23.7% -23.7% -23.4% -16.6% -13.9% -10.1% -10.12%
OCF 3Y 4.6% 6.9% 6.8% 8.0% 6.7% 8.7% 9.5% 6.6% 5.3% 4.3% 1.5% -4.2% -5.1% -9.9% -10.3% -12.1% -9.5% -8.6% -6.4% 0.4% 0.38%
OCF 5Y 10.6% 13.3% 14.1% 14.2% 14.0% 13.4% 10.2% 6.4% 2.3% -1.3% -2.2% -2.7% -2.1% -2.4% -1.0% -0.8% 0.4% 3.6% 3.1% 1.9% 1.85%
Assets 3Y 3.1% 3.1% 12.9% 12.9% 12.9% 12.9% 14.7% 14.7% 14.7% 14.7% 18.7% 18.7% 18.7% 18.7% 12.9% 12.9% 12.9% 12.9% 8.3% 8.3% 8.33%
Assets 5Y 3.6% 3.6% 8.5% 8.5% 8.5% 8.5% 9.1% 9.1% 9.1% 9.1% 13.5% 13.5% 13.5% 13.5% 14.5% 14.5% 14.5% 14.5% 12.3% 12.3% 12.31%
Equity 3Y -3.9% -3.9% 14.0% 14.0% 14.0% 14.0% 17.8% 17.8% 17.8% 17.8% 22.5% 22.5% 22.5% 22.5% 8.2% 8.2% 8.2% 8.2% 3.7% 3.7% 3.74%
Book Value 3Y -1.8% -2.1% 15.4% 14.9% 15.0% 15.1% 19.2% 19.0% 18.3% 18.4% 23.3% 23.3% 23.3% 23.2% 8.9% 8.9% 8.9% 8.6% 3.9% 3.8% 3.81%
Dividend 3Y 6.3% 6.1% 5.5% 5.2% 5.1% 5.0% 4.6% 3.8% 2.8% 2.5% 2.6% 2.6% 2.5% 2.3% 2.3% 2.3% 2.2% 1.8% 1.5% 1.4% 1.44%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.42 0.41 0.51 0.58 0.59 0.57 0.61 0.61 0.54 0.43 0.39 0.32 0.17 0.09 0.07 0.08 0.10 0.10 0.08 0.11 0.114
Earnings Stability 0.90 0.81 0.82 0.85 0.86 0.81 0.87 0.89 0.83 0.66 0.44 0.29 0.13 0.05 0.01 0.00 0.03 0.08 0.23 0.37 0.370
Margin Stability 0.96 0.97 0.97 0.96 0.96 0.96 0.97 0.97 0.97 0.96 0.96 0.95 0.94 0.94 0.93 0.93 0.93 0.92 0.92 0.93 0.929
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.87 0.81 0.84 0.87 0.89 0.91 0.95 1.00 0.96 0.92 0.90 0.89 0.88 0.88 0.89 0.93 0.98 0.99 0.98 0.96 0.959
Earnings Smoothness 0.72 0.62 0.67 0.72 0.76 0.80 0.88 1.00 0.89 0.77 0.71 0.67 0.63 0.65 0.70 0.81 0.95 0.98 0.96 0.90 0.904
ROE Trend 0.15 0.23 -0.00 0.00 -0.01 -0.01 0.00 -0.08 -0.16 -0.25 -0.21 -0.24 -0.27 -0.28 -0.21 -0.17 -0.12 -0.09 -0.03 0.01 0.011
Gross Margin Trend 0.01 0.03 0.04 0.04 0.05 0.05 0.03 0.01 -0.01 -0.03 -0.05 -0.07 -0.08 -0.08 -0.08 -0.06 -0.05 -0.04 -0.03 -0.02 -0.022
FCF Margin Trend -0.02 0.01 -0.05 -0.06 -0.10 -0.10 -0.07 -0.15 -0.17 -0.26 -0.24 -0.23 -0.14 -0.10 -0.09 -0.05 -0.04 0.03 0.06 0.13 0.129
Sustainable Growth Rate 34.1% 39.3% 34.5% 37.4% 39.5% 41.6% 31.9% 27.9% 23.4% 18.6% 12.4% 8.2% 4.0% 1.5% 0.0% 0.1% 0.8% 0.6% 0.0% 1.9% 1.90%
Internal Growth Rate 19.7% 23.5% 21.4% 23.6% 25.3% 27.1% 20.7% 17.7% 14.4% 11.1% 7.0% 4.5% 2.2% 0.8% 0.0% 0.1% 0.4% 0.3% 0.0% 0.9% 0.91%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.12 1.16 1.13 1.10 1.01 1.01 1.00 0.94 0.96 0.92 0.99 1.06 1.21 1.26 1.32 1.26 1.28 1.37 1.43 1.46 1.458
FCF/OCF 0.86 0.84 0.72 0.71 0.68 0.66 0.68 0.57 0.43 0.25 0.21 0.15 0.23 0.24 0.24 0.24 0.23 0.30 0.36 0.48 0.476
FCF/Net Income snapshot only 0.693
OCF/EBITDA snapshot only 0.947
CapEx/Revenue 6.3% 7.9% 13.4% 13.7% 14.3% 15.4% 14.0% 17.1% 22.2% 27.0% 28.9% 31.8% 30.8% 30.4% 30.8% 29.3% 29.6% 27.9% 25.7% 22.3% 22.25%
CapEx/Depreciation snapshot only 2.639
Accruals Ratio -0.04 -0.06 -0.04 -0.04 -0.01 -0.00 0.00 0.02 0.01 0.02 0.00 -0.01 -0.04 -0.04 -0.04 -0.04 -0.04 -0.05 -0.06 -0.07 -0.070
Sloan Accruals snapshot only -0.067
Cash Flow Adequacy snapshot only 0.855
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 2.3% 2.4% 2.5% 2.6% 3.2% 3.3% 3.1% 2.8% 2.9% 3.3% 3.1% 3.0% 2.7% 2.6% 2.9% 3.0% 2.6% 3.0% 3.2% 2.8% 1.82%
Dividend/Share $3.89 $4.02 $4.15 $4.29 $4.44 $4.59 $4.69 $4.76 $4.83 $4.91 $4.98 $5.03 $5.09 $5.15 $5.22 $5.29 $5.37 $5.41 $5.48 $5.53 $5.62
Payout Ratio 54.2% 51.4% 50.0% 48.8% 48.1% 47.5% 49.1% 52.8% 57.6% 63.4% 70.0% 78.1% 88.0% 95.4% 99.9% 99.5% 97.2% 98.1% 100.0% 94.1% 94.13%
FCF Payout Ratio 56.2% 52.7% 61.7% 62.1% 70.1% 71.5% 72.5% 99.1% 1.4% 2.7% 3.4% 4.9% 3.1% 3.2% 3.2% 3.3% 3.3% 2.4% 1.9% 1.4% 1.36%
Total Payout Ratio 58.3% 56.9% 56.8% 61.2% 72.0% 80.1% 90.4% 90.7% 83.9% 78.5% 74.5% 81.4% 91.5% 1.0% 1.2% 1.3% 1.3% 1.3% 1.3% 1.1% 1.12%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.15 0.15 0.16 0.16 0.16 0.16 0.14 0.12 0.10 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.070
Buyback Yield 0.2% 0.3% 0.3% 0.7% 1.6% 2.2% 2.6% 2.0% 1.3% 0.8% 0.2% 0.1% 0.1% 0.2% 0.6% 1.0% 1.0% 1.0% 0.9% 0.6% 0.55%
Net Buyback Yield -0.1% -0.0% 0.1% 0.5% 1.4% 2.1% 2.4% 1.8% 1.1% 0.6% 0.0% -0.0% -0.1% -0.0% 0.2% 0.6% 0.7% 0.7% 0.7% 0.2% 0.22%
Total Shareholder Return 2.2% 2.3% 2.6% 3.1% 4.6% 5.3% 5.6% 4.6% 4.0% 3.9% 3.1% 3.0% 2.6% 2.6% 3.1% 3.6% 3.4% 3.7% 3.8% 3.1% 3.07%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.87 0.87 0.87 0.86 0.86 0.86 0.87 0.87 0.88 0.88 0.88 0.87 0.88 0.88 0.88 0.90 0.89 0.89 0.88 0.87 0.873
Interest Burden (EBT/EBIT) 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.96 0.95 0.94 0.93 0.92 0.91 0.91 0.92 0.91 0.91 0.92 0.917
EBIT Margin 0.47 0.49 0.50 0.51 0.52 0.52 0.51 0.50 0.48 0.46 0.44 0.43 0.40 0.39 0.38 0.37 0.37 0.36 0.35 0.36 0.364
Asset Turnover 0.90 0.94 0.83 0.86 0.89 0.92 0.77 0.75 0.73 0.70 0.59 0.56 0.54 0.53 0.46 0.47 0.49 0.51 0.50 0.53 0.526
Equity Multiplier 2.07 2.07 1.96 1.96 1.96 1.96 1.86 1.86 1.86 1.86 1.89 1.89 1.89 1.89 2.01 2.01 2.01 2.01 2.11 2.11 2.113
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $7.18 $7.82 $8.30 $8.80 $9.22 $9.67 $9.55 $9.01 $8.39 $7.75 $7.11 $6.44 $5.78 $5.40 $5.22 $5.32 $5.53 $5.52 $5.48 $5.87 $5.87
Book Value/Share $9.80 $9.82 $14.24 $14.28 $14.34 $14.45 $15.91 $15.91 $15.91 $15.91 $18.47 $18.43 $18.39 $18.37 $18.39 $18.45 $18.53 $18.49 $17.82 $17.80 $18.46
Tangible Book/Share $4.86 $4.86 $9.49 $9.51 $9.55 $9.63 $10.99 $10.99 $10.99 $10.99 $13.46 $13.43 $13.40 $13.38 $13.37 $13.41 $13.47 $13.44 $12.82 $12.81 $12.81
Revenue/Share $17.89 $18.79 $19.60 $20.30 $21.07 $21.87 $21.86 $21.29 $20.55 $19.77 $19.15 $18.32 $17.51 $17.08 $17.02 $17.52 $18.28 $18.89 $19.37 $20.17 $20.28
FCF/Share $6.92 $7.62 $6.72 $6.91 $6.33 $6.42 $6.47 $4.80 $3.47 $1.80 $1.47 $1.03 $1.63 $1.60 $1.63 $1.59 $1.65 $2.28 $2.85 $4.07 $4.09
OCF/Share $8.05 $9.11 $9.35 $9.69 $9.35 $9.79 $9.52 $8.45 $8.04 $7.14 $7.02 $6.85 $7.02 $6.79 $6.87 $6.71 $7.06 $7.55 $7.83 $8.56 $8.61
Cash/Share $7.01 $7.02 $10.40 $10.43 $10.47 $10.55 $9.90 $9.90 $9.90 $9.90 $9.37 $9.35 $9.33 $9.32 $8.25 $8.28 $8.31 $8.29 $5.35 $5.34 $5.61
EBITDA/Share $9.46 $10.20 $10.74 $11.37 $11.89 $12.42 $12.25 $11.71 $11.08 $10.39 $9.85 $9.25 $8.55 $8.26 $8.21 $8.32 $8.72 $8.87 $9.04 $9.04 $9.04
Debt/Share $7.60 $7.61 $8.77 $8.79 $8.82 $8.89 $9.91 $9.91 $9.91 $9.91 $12.27 $12.24 $12.21 $12.20 $14.79 $14.84 $14.91 $14.88 $16.86 $16.84 $16.84
Net Debt/Share $0.59 $0.59 $-1.64 $-1.64 $-1.65 $-1.66 $0.01 $0.01 $0.01 $0.01 $2.89 $2.89 $2.88 $2.88 $6.55 $6.57 $6.60 $6.58 $11.51 $11.50 $11.50
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 9.469
Altman Z-Prime snapshot only 18.410
Piotroski F-Score 8 8 8 9 9 9 6 4 4 4 4 4 4 4 4 5 6 6 7 8 8
Beneish M-Score -2.36 -2.51 -2.51 -2.49 -2.34 -2.34 -2.33 -2.24 -2.26 -2.19 -2.44 -2.48 -2.61 -2.66 -2.61 -2.57 -2.57 -2.62 -2.64 -2.69 -2.688
Ohlson O-Score snapshot only -9.599
ROIC (Greenblatt) snapshot only 29.26%
Net-Net WC snapshot only $-4.99
EVA snapshot only $3002095087.83
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 91.46 90.99 91.40 91.11 91.71 91.96 92.73 98.62 98.41 92.16 88.54 85.14 83.01 82.84 82.83 82.49 83.04 82.54 83.24 83.79 83.792
Credit Grade snapshot only 4
Credit Trend snapshot only 1.306
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms